Author Correction: Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial.

Nature medicine2024PMID: 38409593

View on PubMed DOI: 10.1038/s41591-024-02883-1

Authors

Wadden, Thomas A; Chao, Ariana M; Machineni, Sriram; Kushner, Robert; Ard, Jamy; Srivastava, Gitanjali; Halpern, Bruno; Zhang, Shuyu; Chen, Jiaxun; Bunck, Mathijs C; Ahmad, Nadia N; Forrester, Tammy